BRIEF-Catalyst Pharmaceuticals Q1 Revenue USD 141.4 Million Vs. IBES Estimate USD 131.5 Million

Reuters
08 May
BRIEF-Catalyst Pharmaceuticals Q1 Revenue USD 141.4 Million Vs. IBES Estimate USD 131.5 Million

May 07 (Reuters) - Catalyst Pharmaceuticals Q1 adjusted net income USD 86.6 million vs. IBES estimate USD 44.1 million.

  • Q1 operating income USD 63.4 million vs. IBES estimate USD 53.9 million
  • Q1 net income USD 56.7 million
  • outlook FY revenue USD 545-565 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10